Ultragenyx Pharmaceutical Stock (NASDAQ: RARE) stock price, news, charts, stock research, profile.
Open | $56.62 |
Close | $56.75 |
Volume / Avg. | 533.27K / 893.46K |
Day Range | $56.00 - $57.54 |
52 Wk Range | 31.52 - 58.12 |
Market Cap | $5.23B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 75 |
Short Interest | 5.26% |
Days to Cover | 6.56 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) through any online brokerage.
Other companies in Ultragenyx Pharmaceutical’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ionis Pharmaceuticals (NASDAQ:IONS), Alkermes (NASDAQ:ALKS) and TG Therapeutics (NASDAQ:TGTX).
Ultragenyx Pharmaceutical has a consensus price target of $91.72.
The stock price for Ultragenyx Pharmaceutical (NASDAQ: RARE) is $56.75 last updated August 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Ultragenyx Pharmaceutical.
Ultragenyx Pharmaceutical’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Ultragenyx Pharmaceutical.
Ultragenyx Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.